Related Experiment Video
Updated: Aug 13, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
E-cadherin gene (CDH1) promoter methylation as the second hit in sporadic diffuse gastric carcinoma
J C Machado1, C Oliveira, R Carvalho
1IPATIMUP, 4200 Porto, Portugal.
Abstract:
In diffuse gastric carcinoma, despite common E-cadherin gene (CDH1) mutations, tumors show absence of CDH1 loss of heterozigosity (LOH) in most cases. This observation challenges the classical two-hit model of tumor suppressor gene inactivation. In order to investigate whether or not CDH1 promoter methylation may function as the second hit we analysed a series of 23 sporadic gastric carcinomas for the presence of CDH1 mutations, CDH1 promoter methylation, LOH and E-cadherin expression. CDH1 mutations were detected in nine of the 16 (56.3%) diffuse gastric carcinomas and in none of the seven intestinal gastric carcinomas. In diffuse gastric carcinomas harboring CDH1 mutations, LOH was observed in a single case. Loss of plasma membrane E-cadherin expression was consistently found in all nine cases with CDH1 mutation, suggesting that tumors inactivated the remaining CDH1 allele via a different mechanism. CDH1 promoter methylation was observed in nine of the 16 (56.3%) diffuse-type gastric carcinoma cases, including six of the nine cases (66.7%) harboring CDH1 mutations. CDH1 promoter methylation was also seen in two (28.6%) intestinal-type cases. Our results show that CDH1 promoter methylation is the second hit in more than half of the sporadic diffuse gastric carcinoma cases harboring CDH1 mutations.
Insights
In diffuse gastric cancer, E-cadherin gene (CDH1) promoter methylation acts as the second hit, inactivating tumor suppressor genes. This finding explains CDH1 mutations without loss of heterozygosity in many gastric carcinoma cases.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Diffuse gastric carcinoma frequently exhibits E-cadherin gene (CDH1) mutations.
- Absence of CDH1 loss of heterozygosity (LOH) in most tumors challenges the classical two-hit tumor suppressor gene inactivation model.
Purpose of the Study:
- Investigate if CDH1 promoter methylation serves as the second hit in gastric tumorigenesis.
- Analyze the relationship between CDH1 mutations, methylation, LOH, and E-cadherin expression.
Main Methods:
- Analysis of 23 sporadic gastric carcinomas.
- Detection of CDH1 mutations, CDH1 promoter methylation, LOH, and E-cadherin expression.
Main Results:
- CDH1 mutations found in 56.3% of diffuse gastric carcinomas; none in intestinal type.
- LOH observed in only one diffuse gastric carcinoma with CDH1 mutation.
- CDH1 promoter methylation detected in 56.3% of diffuse gastric carcinomas, including 66.7% with CDH1 mutations.
Conclusions:
- CDH1 promoter methylation is the second hit mechanism in over half of sporadic diffuse gastric carcinomas with CDH1 mutations.
- This methylation explains E-cadherin loss of expression when LOH is absent.
Related Concept Videos
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Structure of Cadherins
Cadherins in Tissue Organization
Cell Sorting During Development
Cell sorting plays an...

